ChemoSen Cancer Research Results

ChemoSen, chemo-sensitization: Click to Expand ⟱
Source:
Type:
The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”.

Possible Chemo-Sensitizers:
-Curcumin
-Resveratrol
-EGCG
-Quercetin
-Genistein
-Berberine
-Piperine: alkaloid from black pepper
-Ginsenosides: active components of ginseng
-Silymarin
-Allicin
-Lycopene
-Ellagic acid
-Caffeic acid phenethyl ester
-flavopiridol
-oleandrin
-Ursolic acid
-butein
-Betulinic acid



AML, Acute Myeloid Leukemia: Click to Expand ⟱
Acute Myeloid Leukemia

Scientific Papers found: Click to Expand⟱
2572- ART/DHA,  SRF,    Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
- in-vitro, AML, NA
CHOP/DDIT3↑, Mcl-1↓, ChemoSen↑, selectivity↑,
6354- DRE,    Taraxacum officinale L. in leukemia and lymphoma: current knowledge and prospects for horticulture
- Review, AML, NA
ROS↑, mt-Apoptosis↑, TumCCA↑, PI3K↓, Akt↓, STAT3↓, Dose↝, *hepatoP↑, Casp8↑, mtDam↑, TumCD↑, selectivity↑, DNAdam↑, BAX↑, P53↑, Bcl-2↓, CSCs↓, *toxicity↓, tumCV↓, Imm↑, FAK↓, mTOR↓, ChemoSen↑, eff↝, eff↑,
7588- I3C,    Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells
- in-vitro, AML, NA
TumCG↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, BAX↑, PUMA↑, NOXA↑, APAF1↑, NF-kB↓, IAP1↓, Bcl-xL↓, Bcl-2↓, XIAP↓, Myc↓, ChemoSen↑, Casp9↑, cl‑PARP↑, eff↑,
8021- IVM,    The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
- vitro+vivo, AML, HL-60 - NA, lymphoma, U937 - NA, Pca, DU145
AntiP↑, TumCD↑, selectivity↑, TumCG↓, i-Chl↑, ROS↑, ChemoSen↑,
8259- LCA,    Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid
- in-vitro, BC, MCF7 - in-vitro, AML, HL-60
ChemoSen↑, Apoptosis↑, cl‑PARP↑, Bcl-2↓, Bax:Bcl2↑,
1836- VitC,  VitK3,  Chemo,    Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib
- in-vitro, AML, NA
tumCV↓, selectivity↑, Apoptosis↑, eff↑, ChemoSen↑,

Showing Research Papers: 1 to 6 of 6

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0)

AntiP↑, 1,  

Redox & Oxidative Stress(tgid=1)

ROS↑, 2,  

Mitochondria & Bioenergetics(tgid=3)

mtDam↑, 1,   XIAP↓, 1,  

Cell Death(tgid=5)

Akt↓, 1,   APAF1↑, 1,   Apoptosis↑, 3,   mt-Apoptosis↑, 1,   BAX↑, 2,   Bax:Bcl2↑, 1,   Bcl-2↓, 3,   Bcl-xL↓, 1,   Casp8↑, 1,   Casp9↑, 1,   IAP1↓, 1,   Mcl-1↓, 1,   Myc↓, 1,   NOXA↑, 1,   PUMA↑, 1,   TumCD↑, 2,  

Transcription & Epigenetics(tgid=7)

tumCV↓, 2,  

Protein Folding & ER Stress(tgid=8)

CHOP/DDIT3↑, 1,  

DNA Damage & Repair(tgid=10)

DNAdam↑, 1,   P53↑, 2,   cl‑PARP↑, 2,  

Cell Cycle & Senescence(tgid=11)

P21↑, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12)

CSCs↓, 1,   mTOR↓, 1,   PI3K↓, 1,   STAT3↓, 1,   TumCG↓, 2,  

Migration(tgid=13)

i-Chl↑, 1,   FAK↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

Imm↑, 1,   NF-kB↓, 1,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↑, 6,   Dose↝, 1,   eff↑, 3,   eff↝, 1,   selectivity↑, 4,  

Clinical Biomarkers(tgid=22)

Myc↓, 1,  
Total Targets: 42

Pathway results for Effect on Normal Cells:


Functional Outcomes(tgid=23)

hepatoP↑, 1,   toxicity↓, 1,  
Total Targets: 2

Scientific Paper Hit Count for: ChemoSen, chemo-sensitization
1 Artemisinin
1 Sorafenib (brand name Nexavar)
1 Dandelion Root
1 Indole-3-carbinol
1 Ivermectin
1 Licochalcone A
1 Vitamin C (Ascorbic Acid)
1 VitK3,menadione
1 Chemotherapy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:2  Cells:%  prod#:%  Target#:1106  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page